Archived Insight | July 23, 2020
During the COVID-19 pandemic it has become clear that organizations with robust software capabilities were able to sustain and in some cases grow their operations and programs. And the software components that are essential for these efficiencies and better support business continuity will be looked at more closely than ever by business leadership.
Share this page
When it comes to selecting the best software solution for your business needs, the "build" or "buy" decision may still be relevant. For the past 15-20 years, there has been more motivation to buy rather than build, as a wide variety of commercial off the shelf (COTS) software packages became available in the marketplace. COTS packages were often not only less expensive, but much faster to deploy when compared to the time required to develop a custom application. In recent years, however, new software development tools, software and integration frameworks (allowing integration of more than one application), and the introduction of agile development techniques has reignited the build versus buy debate.
When it comes to determining the best software solution for your organization, how will you decide whether to pick the flexibility of building your own software or selecting a time-tested COTS product? Organizations or businesses that find they have unique requirements or specialized customer needs frequently face this dilemma. While costs may be one criteria for making this decision, it is also critically important to consider efficiency gains, functional capabilities, reliability and support to ultimately find the solution that will be the best overall fit for your organization.
Most organizations with the mission of serving participants of a benefit plan or membership group are typically not in the software development business. Therefore, before proceeding with a build versus buy analysis you should perform the following market research:
Once these steps have been performed, and the organization isn’t convinced buying a solution is not the best alternative, a full build versus buy analysis should be performed.
The true costs and benefits of a build versus buy decision is not just in the acquisition. At a minimum, organizations should compare the following items when considering their options:
The analyses of the prior list will help guide the decision, but there are unique attributes your organization needs to consider. Segal has assisted many clients in defining and benchmarking these unique considerations.
To assist organizations in making this challenging and important decision, we have laid out some of the common advantages and disadvantages associated with each option. It is important to remember that each situation can be unique based on the current capabilities of vendors servicing the marketplace, and the priorities of each organization. Here are some examples:
These are just a sample of the advantages and disadvantages of each alternative. Organizations often start with the assumption they will need to build, but only after performing a marketplace analysis of COTS products can they make an informed decision.
Your buy versus build decisions will have major long-term impacts on your organization. It is important that all stakeholders understand why and how you arrived at your decision. Segal has invested in research and tools that can help facilitate the decision-making process, including:
Finding the right consulting partner can help your project and operations run smoothly and enhance member satisfaction.
Our team will work with you to understand your unique needs and will make sure you select an effective strategy. Once you've selected the best alternative, we can assist you with the transition process to ensure everything is in place and meets your expectations.
Insurance, Technology, Cybersecurity Awareness Month, Cybersecurity consulting
Multiemployer Plans, Technology, Benefits Technology, ATC
Health, Benefits Administration, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate
This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.
© 2024 by The Segal Group, Inc.Terms & Conditions Privacy Policy California Residents Sitemap Disclosure of Compensation Required Notices
We use cookies to collect information about how you use segalco.com.
We use this information to make the website work as well as possible and improve our offering to you.